1 DoD Smallpox Vaccination Program Policy – Training – Standards – Communication – Safety Assurance – Safety Assessment Science – Quality – Confidence.

Slides:



Advertisements
Similar presentations
Smallpox Vaccination for Response Teams The Decision is Yours! of and.
Advertisements

Hospital Issues and Smallpox Vaccine Lisa G. Kaplowitz, M.D., M.S.H.A. Deputy Commissioner Emergency Preparedness and Response Virginia Department of Health.
Adverse Event Reporting: Getting started Lynn Bahta, R.N., B.S.N Minnesota Department of Health August 2008.
Safe Surgery Dr. Mohamed Selima. The problem: Complications of surgical care have become a major cause of death and disability worldwide. Data from 56.
Smallpox Vaccine Clinic Operations and Management Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
1 Preparing for Smallpox: Post-event Smallpox Response.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Importance of Vaccine Safety Decreases in disease risks and increased attention on vaccine risks Public confidence in vaccine safety is critical Low tolerance.
Influenza Vaccine Surveillance System Pilot Project Pandemic Influenza Vaccine: Doses Administered and Safety Training Conference Atlanta, GA—Aug. 22,
Randy Benson RHQN Executive Director May, Compliance Issues During Survey Compliance Officers monitor healthcare facilities (hospitals and clinics)
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
Introduction Director’ s Welcom e INFLUENZA Department of Defense Seasonal Influenza Vaccination Program Leaders Briefing UNCLASSIFIED.
The Essentials of Perinatal Hepatitis B Prevention A Training Series for Coordinators and Case Managers.
Texas Perinatal Hepatitis B Prevention Program 2 nd Bi-Annual State Conference Designing an Effective Case Management Program Lisa Jacques-Carroll, MSW.
ANTHRAX VACCINE 14 Sep 09 Introduction Department of Defense
Perinatal Hepatitis B Prevention
Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Management of Smallpox Vaccine Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention February 2003.
Back to the Future? Pre-Event Smallpox Vaccination John R. Lumpkin, MD, MPH, FACEP Illinois Department of Public Health.
1 Introdu ction SMALLPOX Department of Defense Individual’s Briefing 9 Oct 08.
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
 Define Medical Reserve Corps (MRC)  Name two ways the MRC benefits local communities  Understand the mission of the Utah County Medical Reserve Corps.
Review of The CDC’s Smallpox Vaccination Program Implementation Kristine Gebbie, R.N., Dr.P.H. NVAC June 2003.
FDA/CBER Role in Smallpox Vaccine Safety Bob Ball, MD, MPH, ScM Chief, Vaccine Safety Branch Office of Biostatistics and Epidemiology CBER, FDA January.
Adult Immunization 2010 Hepatitis B Vaccine Segment
Introduction to Developing a Vaccination Strategy for Smallpox Preparedness Department of Health and Human Services Centers for Disease Control and Prevention.
Washington State Hospital Association Medicaid Quality Incentive ER is for Emergencies Medicaid Quality Incentive ER is for Emergencies Web Conference.
Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:
Vaccine Safety Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention Revised.
Jeff Neccuzi, Director Division of Immunization Services WV Bureau for Public Health.
MEASLES VACCINATION 2015 Update Susan Reeser RN, BSN (406)
Capability Cliff Notes Series PHEP Capability 14—Responder Safety and Health What Is It And How Will We Measure It?
Decision Support for Quality Improvement
M Purpose Improvement Tools/Methods Limitations / Lessons Learned Results Process Improvement Improving Hospital-Acquired Pressure Ulcers at Discharge.
National Smallpox Vaccination Update Joseph M. Henderson Centers for Disease Control and Prevention.
Smallpox Vaccination: Federal Activities Walter A. Orenstein, M.D. National Immunization Program Centers for Disease Control and Prevention.
Preparing for Vaccine Administration: Warnings, Precautions and Contraindications Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention February 2003.
1 08 Feb 07 Anthrax Vaccine Immunization Program Individual Briefing.
Introduction Director’ s Welcom e INFLUENZA Department of Defense Influenza Vaccination Program Briefing UNCLASSIFIED.
Approved: 9 Jun DoD Leader’s Briefing: Force Health Protection Against Anthrax.
Smallpox Vaccine Program: Communications with the Public and Stakeholders Department of Health and Human Services Centers for Disease Control and Prevention.
Assessing Hospital and Health System Preparedness and Response Helen Burstin, M.D., M.P.H. Director Center for Primary Care Research Agency for Healthcare.
DoD Smallpox Vaccination Program Science – Quality – Confidence – Care 3 June 2003 COL John D. Grabenstein, RPh, PhD Military Vaccine (MILVAX) Agency U.S.
Colorado’s Health Emergency Line for the Public (COHELP): Addressing Surge Capacity through Information Exchange Gregory M. Bogdan, Ph.D. Research Director.
Service Member Receives Vaccine NO REACTION LOCAL REACTION (Occur more often in women than men) Document. Educate. Continue to screen for exclusion criteria.
Plenary #2 -- Grow Promoting Registry Growth through Programmatic Collaboration and Data Quality Improvement Initiatives Plenary #2 -- Grow Promoting Registry.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
A Model For A Collaborative Social Work/Public Health Response to Traumatic and Catastrophic Events: Lessons Learned from Katrina by: Susan A. Hoffpauir,
Update from the 2010 National Influenza Vaccine Summit meeting L.J Tan Co-chair, National Influenza Vaccine Summit Director, Medicine and Public Health,
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
PREPAREDNESS PLANNING FOR EMERGING INFECTIOUS DISEASE HPP Ebola Supplemental funding.
Walter Reed National Vaccine Healthcare Center (VHC) Network Vaccine Adverse Events Diagnosis, Evaluation, Management & Reporting Guidelines for Quality.
The Medical College of Georgia HIPAA Privacy Rule Orientation.
New Hire HIPAA Orientation. HIPAA Overview HIPAA is an acronym that stands for the Health Insurance Portability and Accountability Act of HIPAA.
Strategic National Stockpile Points of Dispensing (PODs)
Vaccination POD Just-in-Time Training. A list of Vaccinators and Vaccinator Assistants at each station will be maintained by the Administrative Representative.
Kingdom of Bahrain Dr. Naeema Isa Al Sabaeei 2014
Hepatitis C Virus Program in Chicago
Department of Legal Medicine Armed Forces Institute of Pathology
Expeditionary Combat Readiness Center Medical Deployment/Redeployment
VFC Site Visit Questionnaire and AFIX as Tools for Quality Assessment
Laurie L. Duran, APRN Lorne McCoy, IM Program Officer
Colorado’s Health Emergency Line for the Public (COHELP): Addressing Surge Capacity through Information Exchange Gregory M. Bogdan, Ph.D. Research Director.
Smallpox Vaccine Contraindications and Screening
Smallpox Vaccinee Evaluation and Follow-Up
TRACE INITIATIVE: Confidentiality, Data Security, and Procedures for Protocol Violation or Adverse Event.
Presentation transcript:

1 DoD Smallpox Vaccination Program Policy – Training – Standards – Communication – Safety Assurance – Safety Assessment Science – Quality – Confidence – Care 29 Jan 03 COL John D. Grabenstein, RPh, PhD Deputy Director for Military Vaccines Office of the Army Surgeon General

2 DoD Smallpox Vaccination Policy Announced by President Bush, 13 Dec 02. –Vaccinating troops before an attack is best way to ensure they are protected and can continue their missions. Several Stages: –Stage 1a: Smallpox Epidemic Response Teams (SERTs). 2,000 to 5,000 people, beginning mid-Dec 02. –Stage 1b: Medical Teams for Hospitals & Large Clinics. 10,000 to 25,000 people, beginning early Jan 03. –Stage 2: Mission-Critical Forces, especially CENTCOM. Up to 500,000 troops, beginning early Jan 03. Clinical policies consistent with FDA, CDC, and ACIP.

3 DoD Smallpox Vaccination Program as of 31 Jan 03: Healthcare workers vaccinated:3,665 * * # of combat troops vaccinated not released publicly; provided to CDC & FDA, along with all other safety-surveillance data. People exempted from smallpox vaccine:10% to 40% * * Includes both admin + clinical exemptions, varies by setting –Self > household Skin > immune > pregnancy > allergy Take: Primary— 3 jabs,96%(186/194) Revaccination—15 jabs, 99%(297/298) Adverse Events: Expected temporary reactions seen. –3% overall lost one or more days of work. Primary—4% to 5%. Revaccination—1% to 2% –Significant Adverse Events: Encephalitis-1-recovered. GV-1-mild. –Patients needing vaccinia immune globulin (VIG): zero. –Deaths: zero.

4 Screen & Vaccinate Acute Events Chronic, Rare, Delayed, Unexpected Vaccinia Safety Assessment Day 6 to 8 (“take”) Vaccination Day Days 0 to 30Months to Decades Sick-call surveillance Exempt?Take? Rate?Inadvertent inoculation How many? Why?Symptoms:Eczema vaccinatum Which? Rate? Severity?Progressive vaccinia Allergic reactions?Sick call:Encephalitis Why? How often?Hospitalizations, etc. How many doses / vial? Limited duty:Vaccinia immune globulin (VIG) requests Why? How long? Time course?CDC: Prospective pregnancy registry Vaccine Adv Event Rpt System (VAERS) Analyzable medical notesAnalyzable medical notes Defense Medical Surveillance System 30-day diary cardsVaccine Healthcare Ctr (VHC) referrals Def Med Surveillance System VIG requests (DMSS)Millennium Cohort Study ThousandsThousandsAll Sociologic Studies Human Factors 17 Dec 02

5

6

7

8

9

10 Precautions in Vaccination Education up front and throughout process Screening for contraindications (same as FDA and ACIP) Periodic HIV screening Pregnancy screening and testing QA of Vaccinator: Evaluate take rates among first cohort of people (e.g., 50 to 100) vaccinated by each vaccinator Healthcare Workers: Bandages, sleeves, hand-washing, site- evaluation stations Military-Unique Settings: No hot-bunking with vaccine exempt Documentation: Screening, Vaccination, Take Confirmation, Adverse Events VIG prepositioned around globe, regionally

11 Tools & Resources

12

13

14 Smallpox Vaccination Program – Lessons SVP medical training essential: Screening forms, handouts revised: – Take due care in conducting screening Ample time for questions, screening. Have MD/PA/NP on site Accept verbal history of prior vaccination (supplement with scar, birth date, military entry) Team of 2: The vaccinator and the bandager/documenter Confirm “trace of blood” at vaccination site Place open vial at back of vaccination station, use cool tray Operate bandage-check station for healthcare workers Notify local health departments Check “take” 6-8 d later, triaged, decentralized

15  Chain of Command  Website:   Toll-Free: 877.GET.VACC  CDC National Immunization Hotline:  CDC Bioterrorism Information:  Walter Reed Vaccine Healthcare Center, for help with complicated adverse-event management:  For information on civilian health-care services for members not enrolled to a Military Treatment Facility:  Call: 888.MHS.MMSO ( ) Communication & Information